XNK presents at the 8[th] Innate Killer Summit in La Jolla, San Diego
XNK Therapeutics AB today announced its extensive participation at the 8[th] Annual Innate Killer Summit in La Jolla, San Diego, CA, March 28-30.The Annual Innate Killer Summit is the largest and leading technical, industry-focused, end-to-end innate immune cell therapy meeting to explore frontiers in immunobiology, genetic modification, clinical translation, scalable manufacturing, cryopreservation, and CMC. Over 200 experts from both pharmaceutical industry and academia participate to advance the clinical and phase development of NK, macrophage, γδT and NKT cell therapies for liquid and